B. Riley upgraded shares of ZimVie (NASDAQ:ZIMV - Free Report) to a strong-buy rating in a report issued on Wednesday, April 9th,Zacks.com reports.
Separately, Needham & Company LLC restated a "hold" rating on shares of ZimVie in a research report on Wednesday, April 9th.
Read Our Latest Stock Analysis on ZIMV
ZimVie Stock Down 1.5 %
ZIMV stock traded down $0.14 during mid-day trading on Wednesday, hitting $9.16. 58,485 shares of the company were exchanged, compared to its average volume of 224,633. The company has a market capitalization of $255.08 million, a PE ratio of -0.70 and a beta of 2.14. The firm has a fifty day simple moving average of $11.79 and a 200 day simple moving average of $13.41. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. ZimVie has a twelve month low of $8.56 and a twelve month high of $22.40.
ZimVie (NASDAQ:ZIMV - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.02. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. The firm had revenue of $111.52 million for the quarter, compared to analysts' expectations of $113.67 million. On average, research analysts forecast that ZimVie will post 0.6 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. Barclays PLC grew its position in shares of ZimVie by 338.4% during the third quarter. Barclays PLC now owns 43,437 shares of the company's stock worth $690,000 after acquiring an additional 33,529 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of ZimVie by 66.7% during the third quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company's stock worth $2,911,000 after buying an additional 73,395 shares during the period. Geode Capital Management LLC grew its holdings in ZimVie by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 646,564 shares of the company's stock worth $10,263,000 after buying an additional 15,053 shares in the last quarter. Principal Financial Group Inc. bought a new stake in ZimVie during the 3rd quarter valued at $275,000. Finally, Bank of New York Mellon Corp boosted its position in ZimVie by 0.9% during the 4th quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company's stock worth $1,404,000 after acquiring an additional 943 shares during the period. 95.63% of the stock is currently owned by institutional investors.
About ZimVie
(
Get Free Report)
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Featured Stories
Before you consider ZimVie, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.
While ZimVie currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.